The effects of quinoline antimalarials on endocytosis by Plasmodium falciparum was investigated by measuring parasite haemoglobin, peroxidase uptake and transport vesicle content. Mefloquine, quinine and halofantrine inhibited endocytosis, chloroquine
Despite problems associated with drug resistance and side-effects, quinolines remain widely used for the treatment of severe malaria, for malaria prophylaxis, in artemisinin combination therapy regimens and for the development of novel quinoline drug candidates (1, 2, 11, 16, 19) . The mechanism of action of the 4-aminoquinoline chloroquine (CQ) has been extensively investigated. Intra-erythrocytic malaria parasites ingest erythrocyte cytosol by endocytosis and deliver it to the parasite food vacuole via haemoglobin (Hb) transport vesicles. Hb digestion in the vacuole releases ferriprotoporphyrin IX (FP), which is detoxified by incorporation into inert haemozoin crystals (6) . CQ concentrates in the food vacuole and is thought to dimerize with FP to cause an inhibition of haemozoin formation and lethal accumulation of toxic FP or FP-CQ complexes (5, 9, 14, 21, 22) . Other quinolines have also been found to inhibit haemozoin formation in vitro at concentrations which correlate with their parasiteinhibitory concentrations (4, 5, 7-9, 13, 14) . It supplies a strong argument that they share insignificant; P=0.37). In parallel cultures, parasites were incubated with the quinolines in combination with 40 µM of the protease inhibitors (PIs) ALLN and E64 to inhibit Hb digestion (12) , and subjected to Hb Western blotting (20; Fig. 1B) . Predictably, addition of the PIs increased the Hb levels in control parasites by more than 3-fold (Fig. 1B vs. 1A, control bar). CQ or AQ did not significantly affect Hb levels in parasites in the presence of PIs. Although a reduction in Hb levels was still found with Q and H, it was less profound than that obtained in the absence of PIs (31% and 30% vs. 64% and 84% for Q and H, respectively). Hb uptake inhibition by MQ was also alleviated by the PIs (66% vs. 83% inhibition). This moderation of quinoline effects on Hb levels in the presence of the PIs agrees with published reports that Hb protease inhibitors antagonize quinoline action (18) . It supports the notion that quinolines share FP binding as a mode of action and suggests that their differential effects on the Hb endocytic pathway may be manifestations of differences in physiochemical properties of the individual quinoline-FP complexes. The residual endocytosis inhibition by quinoline-methanols in the presence of PIs may be due to their additional propensity to bind phospholipid membranes (3, 13, 23) which could disrupt the plasma membrane properties required for endocytic vesicle formation. The Hb-dependence of quinoline action may potentially be explored by using erythrocyte-free parasites (15) . However, re-evaluation of the procedure suggests that removal of parasites from their intra-erythrocytic environment usually terminates endocytic activity, precluding the reproducible application of this technique.
To further investigate the effects of the quinolines on endocytosis, an assay was performed using an exogenous indigestible endocytic tracer, horseradish peroxidase (HRP) (17) . Erythrocytes were preloaded with HRP by hypotonic lysis and infected by incubation with enriched schizont-infected erythrocytes. Parasites in the HRP-loaded erythrocytes were exposed to quinolines for 10 hours, released with saponin, lysed with Triton X-100, and their HRP content measured by a colorimetric peroxidase assay (20) .
Consistent with the Hb Western blotting results, MQ, Q and H inhibited HRP uptake by the parasites (Fig. 2) . Surprisingly, AQ produced a comparable inhibition of HRP uptake, while CQ had a weak inhibitory effect.
A C C E P T E D
The apparent incongruity between the inhibition of HRP endocytosis by AQ and the lack of a significant effect on Hb levels by this compound was clarified by a subsequent Hb immunofluorescence microscopy assay. Following quinoline treatment, parasites were released with saponin and fixed on poly-lysine-coated coverslips using paraformaldehyde and glutaraldehyde. After permeation in Triton X-100, the parasites were incubated with rabbit anti-Hb antiserum followed by TRITC-conjugated goat anti-rabbit antibodies and viewed by fluorescence microscopy (15, 20) . The majority of the Hb co-localized with the haemozoin crystal in the parasite food vacuole (Fig. 3A and B, large arrows) .
Additional fluorescent puncta represented Hb transport vesicles in transit from the plasma membrane to the food vacuole (Fig. 3A, small arrows) . Enumeration of the vesicles showed that Q, H and MQ caused a reduction in endocytic vesicle content per parasite, supporting the conclusion that they inhibit endocytosis and, consequently, endocytic vesicle formation ( Fig. 3D-F; table) . CQ-treatment markedly increased vesicle content, consistent with a disruption of normal vesicle trafficking ( Fig. 3B; table) . Unexpectedly, AQ also caused an increase in vesicle content, often strikingly in individual parasites ( Fig. 3C; table) . This suggests that AQ produces a combination of the cellular effects of CQ on the one hand, and of Q, H and MQ on the other -by inhibiting Hb trafficking and endocytosis simultaneously, the net content of Hb in AQ-treated parasites remains largely unaffected. Further investigation of the molecular mechanisms underlying quinoline effects is required to determine if the endocytosis perturbations result from upstream primary effects, or are directly related to the parasiticidal mechanisms of the drugs. 

